More PRNewswire
View Older Stories View Newer Stories-
Sun Pharma's GL0034 (Utreglutide) Demonstrates Significant Weight Loss, Gluco-metabolic and Lipid Lowering Efficacy in Individuals with Obesity in Oral Presentation at the American Diabetes Associatio
-
NeuroBo Pharmaceuticals' DA-1726 Demonstrated Superiority in Weight Loss, Retention of Lean Body Mass, and Lipid-Lowering Effects Compared to Survodutide, in Pre-Clinical Models
-
Study Shows Promising Results for Inhaled Insulin as Treatment for Type 1 Diabetes
-
New Yorkers: Get Ready to Order Lottery Tickets Online with theLotter!
-
2024 Tang Prize Laureates Announced: Six Global Visionaries to Be Honored in Taiwan This September
-
GreenTree to Report First Quarter 2024 Financial Results on June 25, 2024
-
CATL's TENER Energy Storage System Unveiled at ees Europe 2024, Showcasing Breakthrough Technology
-
Sunwoda Supports Europe's Green Development with Sustainable Energy Storage Solutions and Industry Chain Layout at Intersolar Europe 2024
-
Sungrow Unveils EMS3000 and iSolarBPS for ESS at Intersolar Europe 2024
-
Extremism researcher Julia Ebner receives prestigious CEU Open Society Prize
-
Wondershare Filmora 13.5 Unveils Upgraded AI Toolkit for Creators
-
Firefly Aerospace Ready to Launch Alpha FLTA005 for NASA No Earlier Than June 26
-
CoreBev Announces Opening of New Flagship Distillery, Connecticut Distilling
-
If you purchased Taste of the Wild Grain-Free Dog Food in Missouri then a class action may affect your rights
-
Sciwind Biosciences to Highlight Positive Results for Injectable Ecnoglutide (Phase 3), Oral Ecnoglutide (Phase 1), and Novel Amylin Analogs at the American Diabetes Association (ADA) 84th Annual Conf
-
BOXABL Introduces Partner Directory and Commences Initial Launch with over 80 BOXABL Dealers
-
Echo Hospice Receives Prestigious Center of Excellence Award from The Wound Pros
-
New MiniMed™ 780G system data demonstrates ability to address persistent blood sugar challenges for people with type 1 diabetes
-
New Research Indicates the Need for Diabetes Continuous Glucose Monitoring to Address Health Disparities
-
Weight Loss is Associated with Decreased Cancer Risk in Individuals with Obesity
-
Shrivers Hospice Honored with The Wound Pros Center of Excellence Award
-
KORE to Effect a Reverse Stock Split
-
Americare CSS Honored with Center of Excellence Award by The Wound Pros
-
Dr. Richard Park Joins The Wound Pros as a Medical Director
-
Pinnacle Orthopaedics & Sports Medicine Specialists Notifies Individuals of Data Security Incident
-
Ecopetrol reports on the protocolization of the amendment of its bylaws
-
SchoolsFirst Federal Credit Union Ranked #1 in California by Forbes
-
Greenbrier announces webcast and conference call of quarterly financial results
-
Halozyme Announces argenx Receives FDA Approval for VYVGART® Hytrulo Co-Formulated with ENHANZE® for Chronic Inflammatory Demyelinating Polyneuropathy
-
UNDER ARMOUR ANNOUNCES AGREEMENT TO SETTLE CLASS ACTION LITIGATION
-
ENTRÉE RESOURCES ANNOUNCES 2024 AGM RESULTS
-
How to Sell Your Business to an Employee (and How Not to)
-
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
NeuroSense Receives Delisting Notice from Nasdaq and Intends to Appeal
-
Sandstorm Gold Royalties Announces Voting Results from 2024 Annual Shareholder Meeting
-
Bank of America Corporation Announces Fallback Rate (CORRA) as Substitute Base Rate for Certain Outstanding Debt Securities Linked to the Canadian dollar Bankers' Acceptance Rate (CDOR) After June 28,
-
Safehold Announces $750 Million Commercial Paper Note Program
-
INTEGRA REPORTS VOTING RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
-
'Open For An Icon's' Joelle James Stuns with Powerful National Anthem at NBA Finals Game 5
-
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Marvell Technology, Inc. Declares Quarterly Dividend Payment
-
Lilly's tirzepatide reduced obstructive sleep apnea (OSA) severity, with up to 51.5% of participants meeting the criteria for disease resolution
-
Use of Tirzepatide Shown to Improve Sleep Apnea and Cardiovascular Outcomes
-
Common Cholesterol-Lowering Drug Found to Slow Vision Loss in Diabetes Patients
-
Expanded FORWARD Trial Demonstrates Continued Potential for Stem Cell-Derived Islet Cell Therapy to Eliminate Need for Insulin for People with T1D
-
EY Announces Charles Zhang and Lynn Chen-Zhang of Zhang Financial as an Entrepreneur Of The Year® 2024 Michigan and Northwest Ohio Award Winner
-
Integro Bank Welcomes Special Guests, Fender Musical Instruments Corporation, for June's CEO Club Event
-
FDA Roundup: June 21, 2024
-
ISOA Presents Global Achievement Awards at Annual Gala
